Several epidemiological studies have shown an association between infection or inflammation during pregnancy and increased risk of autism in the child. In addition, animal models have illustrated that maternal inflammation during gestation can cause autism-relevant behaviors in the offspring; so called maternal immune activation (MIA) models. More recently, permanent changes in T cell cytokine responses were reported in children with autism and in offspring of MIA mice; however, the cytokine responses of other immune cell populations have not been thoroughly investigated in these MIA models. Similar to changes in T cell function, we hypothesized that following MIA, offspring will have long-term changes in macrophage function. To test this theory, we utilized the poly (I:C) MIA mouse model in C57BL/6J mice and examined macrophage cytokine production in adult offspring. Pregnant dams were given either a single injection of 20 mg/kg polyinosinic-polycytidylic acid, poly (I:C), or saline delivered intraperitoneally on gestational day 12.5. When offspring of poly (I:C) treated dams reached 10 weeks of age, femurs were collected and bone marrow-derived macrophages were generated. Cytokine production was measured in bone marrow-derived macrophages incubated for 24 h in either growth media alone, LPS, IL-4/LPS, or IFN-c/LPS. Following stimulation with LPS alone, or the combination of IFN-c/LPS, macrophages from offspring of poly (I:C) treated dams produced higher levels of IL-12(p40) (p < 0.04) suggesting an increased M1 polarization. In addition, even without the presence of a polarizing cytokine or LPS stimulus, macrophages from offspring of poly (I:C) treated dams exhibited a higher production of CCL3 (p = 0.05). Moreover, CCL3 levels were further increased when stimulated with LPS, or polarized with either IL-4/LPS or IFN-c/LPS (p < 0.05) suggesting a general increase in production of this chemokine. Collectively, these data suggest that MIA can produce lasting changes in macrophage function that are sustained into adulthood.
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Introduction
There is increasing evidence suggesting that an immune insult during gestation can have a profound effect on the developing fetus (Brown, 2012) . For over 30 years, epidemiological research has continued to find associations between maternal infection and increased risk of autism (Atladottir et al., 2010; Chess, 1971 Chess, , 1977 Mednick et al., 1988) . A recent large case-control population based study revealed an increased risk of developing autism spectrum disorder (ASD) with maternal fever, which was attenuated if pregnant mothers used a fever reducing agent (Zerbo et al., 2013) . In addition, reports highlight associations between risk of having a child with autism and increased levels of inflammatory mediators in both the maternal sera and amniotic fluid. These increased inflammatory markers, including macrophage chemotactic protein (MCP)-1/CCL2, matrix metalloproteinase (MMP)-9, C-reactive protein (CRP), interleukins (IL)-4, IL-5, and interferon (IFN)-c (Abdallah et al., 2012a,b; Brown et al., 2013; Goines et al., 2011) , supporting a relationship between maternal immune activation (MIA), aberrant fetal neurodevelopment, and risk for neurodevelopmental disorders such as autism.
Murine models add further support for a role of MIA in altering fetal neurodevelopment (Patterson, 2009; Patterson et al., 2009) . Many of these studies utilize either a maternal influenza infection
